To determine whether BAK partial activation status was associated with sensitivity to anticancer drugs in ovarian cancer cell lines, we assessed the ability of several anticancer drugs to induce apoptosis in the same 13 ovarian cancer cells (Fig. 2a–f and Supplementary Fig. 3a–d). Here, BAK1 is linked to ovarian carcinoma.